Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

BACKGROUND: The EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study was an international, randomized, open-label, assessor-blinded, parallel-group study assessing the efficacy and tolerability of interferon (IFN) beta-1a, 44 mcg subcutaneously (sc) thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Traboulsee, A, AL-Sabbagh, A, Bennett, R, Chang, P, Li, DKB
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374794/
https://www.ncbi.nlm.nih.gov/pubmed/18426595
http://dx.doi.org/10.1186/1471-2377-8-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374794/
https://www.ncbi.nlm.nih.gov/pubmed/18426595
http://dx.doi.org/10.1186/1471-2377-8-11

Ejemplares similares